The FDA cannot deny its participation in bashing the quitter's natural instincts to quit cold turkey or, as with Chantix, leading smokers to falsely believe they could expect to experience the same quitting rates as generated in pharmacology studies in which quitting products, including the patch, were often heavily clothed in support protocols.